Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
1.
Rev Sci Instrum ; 93(10): 105102, 2022 Oct 01.
Article in English | MEDLINE | ID: mdl-36319381

ABSTRACT

A platform has been developed to study laser-direct-drive energy coupling at the National Ignition Facility (NIF) using a plastic sphere target irradiated in a polar-direct-drive geometry to launch a spherically converging shock wave. To diagnose this system evolution, eight NIF laser beams are directed onto a curved Cu foil to generate Heα line emission at a photon energy of 8.4 keV. These x rays are collected by a 100-ps gated x-ray imager in the opposing port to produce temporally gated radiographs. The platform is capable of acquiring images during and after the laser drive launches the shock wave. A backlighter profile is fit to the radiographs, and the resulting transmission images are Abel inverted to infer radial density profiles of the shock front and to track its temporal evolution. The measurements provide experimental shock trajectories and radial density profiles that are compared to 2D radiation-hydrodynamic simulations using cross-beam energy transfer and nonlocal heat-transport models.

2.
Phys Rev Lett ; 127(10): 105001, 2021 Sep 03.
Article in English | MEDLINE | ID: mdl-34533333

ABSTRACT

Statistical modeling of experimental and simulation databases has enabled the development of an accurate predictive capability for deuterium-tritium layered cryogenic implosions at the OMEGA laser [V. Gopalaswamy et al.,Nature 565, 581 (2019)10.1038/s41586-019-0877-0]. In this letter, a physics-based statistical mapping framework is described and used to uncover the dependencies of the fusion yield. This model is used to identify and quantify the degradation mechanisms of the fusion yield in direct-drive implosions on OMEGA. The yield is found to be reduced by the ratio of laser beam to target radius, the asymmetry in inferred ion temperatures from the ℓ=1 mode, the time span over which tritium fuel has decayed, and parameters related to the implosion hydrodynamic stability. When adjusted for tritium decay and ℓ=1 mode, the highest yield in OMEGA cryogenic implosions is predicted to exceed 2×10^{14} fusion reactions.

3.
J Exp Zool A Ecol Integr Physiol ; 335(5): 512-521, 2021 06.
Article in English | MEDLINE | ID: mdl-33949805

ABSTRACT

The widespread use of atrazine, a herbicide used to control weeds, has contributed to the increased contamination of aquatic environments. To assess the toxicological effects of a xenobiotic on a nontarget organism in the laboratory, different models of toxicological exposure systems have been widely used. Therefore, the aim of this study was to evaluate and compare the action of sublethal concentrations of atrazine on the hepatic histology of Oreochromis niloticus, considering two models of exposure: static (where atrazine was only added once) and semi-static (where atrazine was periodically renewed). Fish were exposed to a concentration of 2 ppm atrazine for 15 days, which was verified by high-performance liquid chromatography. The livers were stained with hematoxylin and eosin and histopathological data were collected. In addition, they were submitted to immunohistochemistry for inducible nitric oxide synthase (iNOS). A maximum variation of 45% (static) and 12.5% (semi-static) was observed between the observed and nominal atrazine concentration. Nuclear and cytoplasmic changes were observed in both experimental models. Hepatocytes from the livers of the static system showed a degenerative appearance, while in the semi-static system, intense cytoplasmic vacuolization and necrosis were observed. iNOS positive cells were identified only in macrophages in the hepatocytes of fish in the semi-static system. These results directly showed how the choice of exposure system can influence the results of toxicological tests. However, future analysis investigating the by-products and nitrogen products should be carried out since the histopathological findings revealed the possibility of these compounds serving as secondary contamination routes.


Subject(s)
Atrazine/toxicity , Chemical and Drug Induced Liver Injury/veterinary , Fish Diseases/chemically induced , Herbicides/toxicity , Animals , Atrazine/administration & dosage , Chemical and Drug Induced Liver Injury/pathology , Cichlids , Drug Administration Schedule , Herbicides/administration & dosage , Male , Water Pollutants, Chemical/toxicity
4.
Eur J Med Chem ; 183: 111673, 2019 Dec 01.
Article in English | MEDLINE | ID: mdl-31536894

ABSTRACT

Cryptosporidiosis is a human gastrointestinal disease caused by protozoans of the genus Cryptosporidium, which can be fatal in immunocompromised individuals. The essential enzyme, thymidylate synthase (TS), is responsible for de novo synthesis of deoxythymidine monophosphate. The TS active site is relatively conserved between Cryptosporidium and human enzymes. In previous work, we identified compound 1, (2-amino-4-oxo-4,7-dihydro-pyrrolo[2,3-d]pyrimidin-methyl-phenyl-l-glutamic acid), as a promising selective Cryptosporidium hominis TS (ChTS) inhibitor. In the present study, we explore the structure-activity relationship around 1 glutamate moiety by synthesizing and biochemically evaluating the inhibitory activity of analogues against ChTS and human TS (hTS). X-Ray crystal structures were obtained for compounds bound to both ChTS and hTS. We establish the importance of the 2-phenylacetic acid moiety methylene linker in optimally positioning compounds 23, 24, and 25 within the active site. Moreover, through the comparison of structural data for 5, 14, 15, and 23 bound in both ChTS and hTS identified that active site rigidity is a driving force in determining inhibitor selectivity.


Subject(s)
Cryptosporidium/enzymology , Glutamates/chemistry , Phenylacetates/chemistry , Pyrimidines/chemistry , Pyrroles/chemistry , Thymidylate Synthase/antagonists & inhibitors , Catalytic Domain , Drug Design , Humans , Models, Molecular , Molecular Structure , Protein Binding , Thymidylate Synthase/chemistry
5.
Nutr Metab Cardiovasc Dis ; 29(6): 633-638, 2019 06.
Article in English | MEDLINE | ID: mdl-30956026

ABSTRACT

BACKGROUND AND AIMS: Sunlight exposure is associated with a number of health benefits including protecting us from autoimmunity, cardiovascular disease, obesity and diabetes. Animal studies have confirmed that ultraviolet (UV)-B radiation, independently of vitamin D, can limit diet-induced obesity, metabolic syndrome and atherosclerosis. The aim of this study is to investigate whether exposure to the UV radiation contained in sunlight impacts on these disease parameters. METHODS AND RESULTS: We have trialled an intervention with solar UV in obese and atherosclerosis-prone mice. We have discovered that solar-simulated UV can significantly limit diet-induced obesity and reduce atheroma development in mice fed a diet high in sugar and fat. The optimal regime for this benefit was exposure once a week to solar UV equivalent to approximately 30 min of summer sun. Exposure to this optimal dose of solar UV also led to a significant increase in liver triglycerides which may protect the liver from damage. CONCLUSION: Our results show that the UV contained in sunlight has the potential to prevent and treat chronic disease at sites distant from irradiated skin. A major health challenge going forward will be to harness the power of the sun safely, without risking an increase in skin cancers.


Subject(s)
Adipose Tissue, Brown/radiation effects , Atherosclerosis/prevention & control , Diet, High-Fat , Liver/radiation effects , Obesity/prevention & control , Triglycerides/metabolism , Ultraviolet Therapy , Weight Gain/radiation effects , Adipose Tissue, Brown/metabolism , Adipose Tissue, Brown/physiopathology , Adiposity/radiation effects , Animals , Atherosclerosis/genetics , Atherosclerosis/metabolism , Atherosclerosis/pathology , Disease Models, Animal , Liver/metabolism , Male , Mice, Inbred C57BL , Mice, Knockout, ApoE , Obesity/etiology , Obesity/metabolism , Obesity/physiopathology , Uncoupling Protein 1/metabolism
6.
Nature ; 565(7741): 581-586, 2019 01.
Article in English | MEDLINE | ID: mdl-30700868

ABSTRACT

Focusing laser light onto a very small target can produce the conditions for laboratory-scale nuclear fusion of hydrogen isotopes. The lack of accurate predictive models, which are essential for the design of high-performance laser-fusion experiments, is a major obstacle to achieving thermonuclear ignition. Here we report a statistical approach that was used to design and quantitatively predict the results of implosions of solid deuterium-tritium targets carried out with the 30-kilojoule OMEGA laser system, leading to tripling of the fusion yield to its highest value so far for direct-drive laser fusion. When scaled to the laser energies of the National Ignition Facility (1.9 megajoules), these targets are predicted to produce a fusion energy output of about 500 kilojoules-several times larger than the fusion yields currently achieved at that facility. This approach could guide the exploration of the vast parameter space of thermonuclear ignition conditions and enhance our understanding of laser-fusion physics.

7.
Recent Pat Biotechnol ; 13(3): 170-186, 2019.
Article in English | MEDLINE | ID: mdl-30648529

ABSTRACT

BACKGROUND: The different fields of biotechnology can be classified by colors, as a "rainbow" methodology. In this sense, the red biotechnology, focused on the preservation of health, has been outstanding in helping to solve this challenge through the provision of technologies, including diagnostic kits, molecular diagnostics, vaccines, innovations in cancer research, therapeutic antibodies and stem cells. OBJECTIVE: The main goal of this work is to highlight the different areas within the red Biotechnology. In this sense, we revised some patents regarding red biotechnology as examples to cover this subject. METHODS: A literature search of patents was performed from the followings Patents Database: INPI, USPTO, Esp@cenet, WIPO and Google Patents. RESULTS: Our analysis showed the following numbers from patents found: cancer research (8), diagnosis kit (9), vaccines (8), stem cells (9) and therapeutic antibodies (5), where the United States is the leader for most filled patents in Red Biotechnology. CONCLUSION: This mini-review has provided an update of some patents on Recent Patents in Red Biotechnology. As far as we know, this is the first mini-review report on Red Biotechnology based on patents.


Subject(s)
Biomedical Research/methods , Biotechnology/methods , Cell- and Tissue-Based Therapy/methods , Inventions/statistics & numerical data , Patents as Topic , Pathology, Molecular/methods , Antineoplastic Agents, Immunological/therapeutic use , Biomedical Research/history , Biotechnology/history , Databases, Factual , History, 21st Century , Humans , Reagent Kits, Diagnostic , Vaccines/biosynthesis , Vaccines/chemical synthesis , Vaccines/therapeutic use
8.
Obes Rev ; 19(3): 406-420, 2018 03.
Article in English | MEDLINE | ID: mdl-29243339

ABSTRACT

Adipose tissue plays a significant role in whole body energy homeostasis. Obesity-associated diabetes, fatty liver and metabolic syndrome are closely linked to adipose stress and dysfunction. Genetic predisposition, overeating and physical inactivity influence the expansion of adipose tissues. Under conditions of constant energy surplus, adipocytes become hypertrophic and adipose tissues undergo hyperplasia so as to increase their lipid storage capacity, thereby keeping circulating blood glucose and fatty acids below toxic levels. Nonetheless, adipocytes have a saturation point where they lose capacity to store more lipids. At this stage, when adipocytes are fully lipid-engorged, they express stress signals. Adipose depots (particularly visceral compartments) from obese individuals with a severe metabolic phenotype are characterized by the high proportion of hypertrophic adipocytes. This review focuses on the mechanisms of adipocyte enlargement in relation to adipose fatty acid and cholesterol metabolism, and considers how this may be related to adipose dysfunction.


Subject(s)
Adipocytes/pathology , Adipocytes/physiology , Fatty Acids/metabolism , Lipid Metabolism/physiology , Obesity/physiopathology , Overnutrition/physiopathology , Adipocytes/cytology , Adiposity , Humans , Inflammation Mediators/metabolism , Obesity/metabolism , Overnutrition/complications , Overnutrition/metabolism , Stress, Physiological
9.
Ann Oncol ; 28(5): 996-1004, 2017 May 01.
Article in English | MEDLINE | ID: mdl-28453702

ABSTRACT

BACKGROUND: A phase 2, randomized, placebo-controlled trial was conducted in women with recurrent epithelial ovarian carcinoma to evaluate the efficacy and safety of motolimod-a Toll-like receptor 8 (TLR8) agonist that stimulates robust innate immune responses-combined with pegylated liposomal doxorubicin (PLD), a chemotherapeutic that induces immunogenic cell death. PATIENTS AND METHODS: Women with ovarian, fallopian tube, or primary peritoneal carcinoma were randomized 1 : 1 to receive PLD in combination with blinded motolimod or placebo. Randomization was stratified by platinum-free interval (≤6 versus >6-12 months) and Gynecologic Oncology Group (GOG) performance status (0 versus 1). Treatment cycles were repeated every 28 days until disease progression. RESULTS: The addition of motolimod to PLD did not significantly improve overall survival (OS; log rank one-sided P = 0.923, HR = 1.22) or progression-free survival (PFS; log rank one-sided P = 0.943, HR = 1.21). The combination was well tolerated, with no synergistic or unexpected serious toxicity. Most patients experienced adverse events of fatigue, anemia, nausea, decreased white blood cells, and constipation. In pre-specified subgroup analyses, motolimod-treated patients who experienced injection site reactions (ISR) had a lower risk of death compared with those who did not experience ISR. Additionally, pre-treatment in vitro responses of immune biomarkers to TLR8 stimulation predicted OS outcomes in patients receiving motolimod on study. Immune score (tumor infiltrating lymphocytes; TIL), TLR8 single-nucleotide polymorphisms, mutational status in BRCA and other DNA repair genes, and autoantibody biomarkers did not correlate with OS or PFS. CONCLUSIONS: The addition of motolimod to PLD did not improve clinical outcomes compared with placebo. However, subset analyses identified statistically significant differences in the OS of motolimod-treated patients on the basis of ISR and in vitro immune responses. Collectively, these data may provide important clues for identifying patients for treatment with immunomodulatory agents in novel combinations and/or delivery approaches. TRIAL REGISTRATION: Clinicaltrials.gov, NCT 01666444.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Neoplasm Recurrence, Local/drug therapy , Neoplasms, Glandular and Epithelial/drug therapy , Ovarian Neoplasms/drug therapy , Adjuvants, Immunologic/administration & dosage , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Benzazepines/administration & dosage , Carcinoma, Ovarian Epithelial , Disease-Free Survival , Double-Blind Method , Doxorubicin/administration & dosage , Doxorubicin/analogs & derivatives , Humans , Immunity, Innate/drug effects , Kaplan-Meier Estimate , Middle Aged , Neoplasm Recurrence, Local/mortality , Neoplasms, Glandular and Epithelial/mortality , Ovarian Neoplasms/mortality , Polyethylene Glycols/administration & dosage , Proportional Hazards Models , Treatment Outcome
10.
Article in English | MEDLINE | ID: mdl-26066111

ABSTRACT

Channeling experiments were performed that demonstrate the transport of high-intensity (>10(18)W/cm(2)), multikilojoule laser light through a millimeter-sized, inhomogeneous (∼300-µm density scale length) laser-produced plasma up to overcritical density, which is an important step forward for the fast-ignition concept. The background plasma density and the density depression inside the channel were characterized with a novel optical probe system. The channel progression velocity was measured, which agrees well with theoretical predictions based on large scale particle-in-cell simulations, confirming scaling laws for the required channeling laser energy and laser pulse duration, which are important parameters for future integrated fast-ignition channeling experiments.

11.
Nat Commun ; 5: 5785, 2014 Dec 12.
Article in English | MEDLINE | ID: mdl-25503788

ABSTRACT

The advent of high-intensity lasers enables us to recreate and study the behaviour of matter under the extreme densities and pressures that exist in many astrophysical objects. It may also enable us to develop a power source based on laser-driven nuclear fusion. Achieving such conditions usually requires a target that is highly uniform and spherically symmetric. Here we show that it is possible to generate high densities in a so-called fast-ignition target that consists of a thin shell whose spherical symmetry is interrupted by the inclusion of a metal cone. Using picosecond-time-resolved X-ray radiography, we show that we can achieve areal densities in excess of 300 mg cm(-2) with a nanosecond-duration compression pulse--the highest areal density ever reported for a cone-in-shell target. Such densities are high enough to stop MeV electrons, which is necessary for igniting the fuel with a subsequent picosecond pulse focused into the resulting plasma.

12.
Aliment Pharmacol Ther ; 39(12): 1408-17, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24779703

ABSTRACT

BACKGROUND: Chronic ulcerative colitis (CUC) and colonic Crohn's disease (CD) increase colorectal neoplasia (CRN) risk. While sessile serrated polyp (SSP) is a known cancer precursor, serrated epithelial changes (SEC) are of uncertain prevalence and neoplastic risk. AIM: To assess the serrated lesion detection rates in CUC and CD and documented incidence of subsequent CRN in a retrospective, single-centre cohort study. METHODS: Patients were identified by a central diagnostic index and pathology review confirmed SEC, SSP, CUC and CD diagnoses from 2006-12. Matched controls were identified from among all CUC and CD patients having colonoscopy during the second half of the time period. All were followed for incident CRN, estimated by the Kaplan-Meier method. RESULTS: Between 2006 and 2012, 79 SEC and 10 SSP cases were identified. Detection rates were estimated to be 10/1000 and 2/1000 patients, for SEC and SSP respectively, among 4208 unique CUC or CD patients having colonoscopy from 2010-12. With only 10 cases, SSP patients were not further analysed. Cumulative incidence of subsequent CRN at 1 and 3 years was 12% (95% CI, 0-30%) and 30% (3-57%), respectively, in SEC patients compared to 4% (0-12%) and 9% (0-23%), respectively, in CUC or CD controls (P = 0.047, log-rank). However, this statistical difference was not significant after patients were stratified for history of prior or synchronous dysplasia (P = 0.09). CONCLUSIONS: Serrated epithelial changes and sessile serrated polyps are uncommonly detected by colonoscopy in chronic ulcerative colitis and Crohn's disease patients. Histology with changes of serrated epithelium may be associated with risk of subsequent colorectal neoplasia, however further studies are needed to explore this relationship.


Subject(s)
Colitis, Ulcerative/pathology , Colon/pathology , Crohn Disease/pathology , Intestinal Mucosa/pathology , Adult , Aged , Colitis, Ulcerative/complications , Colitis, Ulcerative/epidemiology , Colonoscopy/methods , Crohn Disease/complications , Crohn Disease/epidemiology , Female , Humans , Incidence , Male , Middle Aged , Neoplasms/epidemiology , Neoplasms/etiology , Retrospective Studies
13.
Int J Non Linear Mech ; 57: 146-153, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24124265

ABSTRACT

An interpolating spline-based approach is presented for modeling multi-flexible-body systems in the divide-and-conquer (DCA) scheme. This algorithm uses the floating frame of reference formulation and piecewise spline functions to construct and solve the non-linear equations of motion of the multi-flexible-body system undergoing large rotations and translations. The new approach is compared with the flexible DCA (FDCA) that uses the assumed modes method [1]. The FDCA, in many cases, must resort to sub-structuring to accurately model the deformation of the system. We demonstrate, through numerical examples, that the interpolating spline-based approach is comparable in accuracy and superior in efficiency to the FDCA. The present approach is appropriate for modeling flexible mechanisms with thin 1D bodies undergoing large rotations and translations, including those with irregular shapes. As such, the present approach extends the current capability of the DCA to model deformable systems. The algorithm retains the theoretical logarithmic complexity inherent in the DCA when implemented in parallel.

14.
Br J Cancer ; 104(12): 1896-905, 2011 Jun 07.
Article in English | MEDLINE | ID: mdl-21654689

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) type 16 is associated with oropharyngeal carcinomas (OPC). Antibodies (Abs) to HPV16 E6 and E7 oncoproteins have been detected in patient sera; however, Abs to other early HPV-derived proteins have not been well explored. METHODS: Antibodies to the HPV16 proteome were quantified using a novel multiplexed bead assay, using C-terminal GST-fusion proteins captured onto Luminex beads. Sera were obtained from untreated patients with OPC (N=40), partners of patients with HPV16+ OPC (N=11), and healthy controls (N=50). RESULTS: Oropharyngeal carcinomas patients with known virus-like capsid particle+ Abs had elevated serum Abs to HPV16 E1, E2, E4, E6, and E7, and L1 antibody levels, but not E5. The ratios of specific median fluorescence intensity to p21-GST compared with controls were E1: 50.7 vs 2.1; E4: 14.6 vs 1.3; E6: 11.3 vs 2.4; E7: 43.1 vs 2.6; and L1: 10.3 vs 2.6 (each P≤0.01). In a validation cohort, HPV16 E1, E2, and E7 antibody levels were significantly elevated compared with healthy control samples (P≤0.02) and partners of OPC patients (P≤0.01). CONCLUSION: Patients with HPV16+ OPC have detectable Abs to E1, E2, and E7 proteins, which are potential biomarkers for HPV-associated OPC.


Subject(s)
Antibodies, Viral/blood , Biomarkers, Tumor/blood , Human papillomavirus 16/immunology , Oncogene Proteins, Viral/immunology , Oropharyngeal Neoplasms/virology , Papillomavirus E7 Proteins/immunology , Proteome/immunology , Repressor Proteins/immunology , Aged , Aged, 80 and over , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Oropharyngeal Neoplasms/diagnosis
15.
Int J Obes (Lond) ; 35(12): 1539-48, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21386801

ABSTRACT

OBJECTIVE: Fat Aussie mice (foz/foz) are morbidly obese, glucose intolerant and have liver steatosis that develops into steatohepatitis on a high-fat diet. The cannabinoid 1 receptor (CB1) antagonist SR141716 has been shown to improve obesity-associated metabolic complications in humans and rodent models. The aim of this study was to assess the effect of SR141716 in foz/foz mice. DESIGN: Male wildtype (WT) and foz/foz mice were fed a chow or high-fat diet (45% saturated fat). Vehicle or SR141716 (10 mg kg(-1) per day) was administered in jelly once daily for 4 weeks from 4 months of age. RESULTS: Foz/foz mice were obese but had less epididymal adipose tissue mass than fat-fed WT mice despite being significantly heavier. Liver weight was increased by twofold in foz/foz compared with WT mice and showed significant steatogenesis associated with impaired liver function. Foz/foz and fat-fed WT mice were glucose intolerant as determined by oral glucose tolerance test. In chow-fed foz/foz mice, SR141716 reduced body weight, liver weight, reversed hepatosteatosis and glucose intolerance. Subcutaneous white adipose tissue gene expression of the macrophage-specific marker Cd68 reflected the improvements in the metabolic status by SR141716 in these mice. CONCLUSION: The results are consistent with the hypothesis that foz/foz mice have defective lipid metabolism, are unable to adequately store fat in adipose tissue but instead sequester fat ectopically in other metabolic tissues (liver) leading to insulin resistance and hepatic steatosis associated with inflammation. Our findings suggest that SR141716 can improve liver lipid metabolism in foz/foz mice in line with improved insulin sensitivity and adipose tissue inflammation.


Subject(s)
Adipose Tissue/metabolism , Fatty Liver/drug therapy , Inflammation/drug therapy , Lipid Metabolism/drug effects , Liver/metabolism , Obesity, Morbid/drug therapy , Obesity, Morbid/metabolism , Piperidines/pharmacology , Pyrazoles/pharmacology , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Adipose Tissue/drug effects , Adipose Tissue/pathology , Animals , Diet, High-Fat , Disease Models, Animal , Fatty Liver/metabolism , Fatty Liver/pathology , Glucose Intolerance/metabolism , Glucose Tolerance Test , Inflammation/etiology , Inflammation/metabolism , Inflammation/pathology , Insulin Resistance , Liver/drug effects , Liver/pathology , Male , Mice , Obesity, Morbid/complications , Rimonabant
16.
Br J Dermatol ; 163(5): 1085-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20716221

ABSTRACT

BACKGROUND: Psoriatic plaques present a complex expression profile, including high levels of cytokines, chemokines and growth factors. Circulating cytokines have been suggested to reflect the activation status of the inflammatory process. OBJECTIVES: To analyse 20 cytokines, chemokines and growth factors in 14 patients with psoriasis vulgaris at the start and during the course of ultraviolet B treatment. METHODS: A multiplex cytokine assay was used. RESULTS: We identified increased serum levels of epidermal growth factor (EGF) (mean 323 vs. 36·6 pg mL⁻¹, P = 0·0001), interleukin (IL)-1 receptor antagonist (mean 39·1 vs. 14·6 pg mL⁻¹, P = 0·02) and tumour necrosis factor-α (mean 7·5 vs. 4·5 pg mL⁻¹, P = 0·04) at baseline in patients with psoriasis compared with matched controls. None of these cytokines was correlated to the severity of the disease (Psoriasis Area and Severity Index) or decreased with phototherapy, suggesting that sources other than lesional skin contribute to the production of these cytokines. Using cluster analysis, we observed coordinate upregulation of EGF, IL-6, macrophage inflammatory protein-1ß and vascular endothelial growth factor. CONCLUSIONS: The sustained high expression of inflammatory circulating cytokines is a potential mechanism linking psoriasis with its extracutaneous comorbidities.


Subject(s)
Epidermal Growth Factor/blood , Interleukin 1 Receptor Antagonist Protein/blood , Psoriasis/metabolism , Biomarkers/blood , Cytokines/blood , Female , Humans , Male , Psoriasis/radiotherapy , Severity of Illness Index , Tumor Necrosis Factor-alpha/blood , Ultraviolet Therapy
17.
Phys Rev Lett ; 104(13): 135002, 2010 Apr 02.
Article in English | MEDLINE | ID: mdl-20481889

ABSTRACT

A multidimensional measurable criterion for central ignition of inertial-confinement-fusion capsules is derived. The criterion accounts for the effects of implosion nonuniformities and depends on three measurable parameters: the neutron-averaged total areal density (rhoR(n)(tot)), the ion temperature (T(n)), and the yield over clean (YOC=ratio of the measured neutron yield to the predicted one-dimensional yield). The YOC measures the implosion uniformity. The criterion can be approximated by chi=(rhoR(n)(tot))(0.8) x (T(n)/4.7)(1.7)YOC(mu)>1 (where rhoR is in g cm(-2), T in keV, and mu approximately 0.4-0.5) and can be used to assess the performance of cryogenic implosions on the NIF and OMEGA. Cryogenic implosions on OMEGA have achieved chi approximately 0.02-0.03.

18.
Br J Dermatol ; 160(2): 325-32, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19016707

ABSTRACT

BACKGROUND: Psoriasis is a disease of dysregulated inflammation and epithelial hyperproliferation in the skin, involving both the innate and adaptive immune system. Psoriatic keratinocytes express high levels of psoriasin (S100A7), a small calcium-binding protein. OBJECTIVES: To determine if patients with active psoriasis have elevated serum levels of psoriasin and psoriasin-specific autoantibodies. METHODS: Blood was collected from 14 patients with psoriasis vulgaris at the start of narrowband ultraviolet (UV) B therapy and from 11 of these patients every 2 weeks during the course of the UVB treatment. Patient and control sera were tested for psoriasin antigen levels by sandwich enzyme-linked immunosorbent assay, and for psoriasin autoantibody titres using recombinant purified psoriasin and overlapping peptides. RESULTS: We confirmed strong and specific expression of psoriasin in psoriatic epidermis by immunohistochemistry. Systemic psoriasin antigen levels tended to be lower in patients (mean 213 ng mL(-1)) than in controls (mean 331 ng mL(-1), P = 0.308) and decreased with increasing disease severity. Psoriasin-specific autoantibodies were detected in a subset of patients with psoriasis and healthy normal donors (mean 0.347 vs. 0.255 units, P = 0.246). The epitopes recognized by the autoantibodies were mapped to an external loop domain of the molecule but did not show corresponding T-cell immunogenicity. CONCLUSIONS: Although psoriasin is overexpressed in psoriatic skin lesions, systemic levels of psoriasin tended to be lower with increasing disease severity, which may be due to the presence of psoriasin-specific autoantibodies. Neither psoriasin nor psoriasin-specific autoantibodies appear to be promising serum biomarkers for clinical psoriasis.


Subject(s)
Autoantibodies/blood , Calcium-Binding Proteins/blood , Keratinocytes/immunology , Psoriasis/immunology , Adult , Biomarkers/blood , Blotting, Western , Calcium-Binding Proteins/immunology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Psoriasis/pathology , Psoriasis/radiotherapy , S100 Calcium Binding Protein A7 , S100 Proteins , Ultraviolet Therapy
19.
Phys Rev Lett ; 98(15): 155001, 2007 Apr 13.
Article in English | MEDLINE | ID: mdl-17501359

ABSTRACT

A novel method by C. Zhou and R. Betti [Bull. Am. Phys. Soc. 50, 140 (2005)] to assemble and ignite thermonuclear fuel is presented. Massive cryogenic shells are first imploded by direct laser light with a low implosion velocity and on a low adiabat leading to fuel assemblies with large areal densities. The assembled fuel is ignited from a central hot spot heated by the collision of a spherically convergent ignitor shock and the return shock. The resulting fuel assembly features a hot-spot pressure greater than the surrounding dense fuel pressure. Such a nonisobaric assembly requires a lower energy threshold for ignition than the conventional isobaric one. The ignitor shock can be launched by a spike in the laser power or by particle beams. The thermonuclear gain can be significantly larger than in conventional isobaric ignition for equal driver energy.

20.
Phys Rev Lett ; 98(2): 025004, 2007 Jan 12.
Article in English | MEDLINE | ID: mdl-17358616

ABSTRACT

Thick, 40 microm plastic shells filled with 25-35 atm of D2 or D3He were imploded on a low-adiabat (alpha approximately 1.3) and with a low-implosion velocity ( approximately 2 x 10(70 cm/s) on the OMEGA laser to generate massive cores of compressed plasma with high areal densities optimal for fast ignition. The targets are driven by 20-kJ relaxation adiabat-shaping laser pulses to keep the inner portion of the shell nearly Fermi degenerate. The measured kinetic energy downshift of proton spectra is in good agreement with the theoretical predictions yielding burn-averaged areal densities of 0.130+/-0.017 g/cm2 and peak rhoR during the burn of about 0.24+/-0.018 g/cm2, the largest rhoR measured on OMEGA to date. The same implosions with empty plastic shells are expected to reach 1.3 g/cm2 across the core (i.e., 2rhoR) enough to stop fast electrons with energies up to 4.5 MeV typical of fast ignition scenarios.

SELECTION OF CITATIONS
SEARCH DETAIL
...